BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 9815651)

  • 1. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of angiogenesis in operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis M; O'Byrne K; Fox S; Whitehouse R; Talbot DC; Harris AL; Gatter KC
    J Pathol; 1996 May; 179(1):80-8. PubMed ID: 8691350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.
    Kakolyris S; Giatromanolaki A; Koukourakis M; Leigh IM; Georgoulias V; Kanavaros P; Sivridis E; Gatter KC; Harris AL
    Cancer Res; 1999 Nov; 59(21):5602-7. PubMed ID: 10554041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
    Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
    Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer.
    Fontanini G; Bigini D; Vignati S; Basolo F; Mussi A; Lucchi M; Chine S; Angeletti CA; Harris AL; Bevilacqua G
    J Pathol; 1995 Sep; 177(1):57-63. PubMed ID: 7472781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
    Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
    Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Gatter KC; Harris AL
    J Pathol; 2000 Oct; 192(2):140-9. PubMed ID: 11004689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Kaklamanis L; Barbatis K; O'Byrne KJ; Theodosssiou D; Harris AL; Gatter KC
    Anticancer Res; 1998; 18(1A):71-6. PubMed ID: 9568058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical study on tumor angiogenic factors in non-small cell lung cancer.
    Aikawa H; Takahashi H; Fujimura S; Sato M; Endo C; Sakurada A; Kondo T; Tanita T; Matsumura Y; Ono S; Saito Y; Sagawa M
    Anticancer Res; 1999; 19(5B):4305-9. PubMed ID: 10628391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
    Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage.
    Juczewska M; Chyczewski L; Telego M; Chyczewska E; Nikliński J; Tańska M; Laudański J
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():254-70. PubMed ID: 9337543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer.
    Yuan A; Yang PC; Yu CJ; Lee YC; Yao YT; Chen CL; Lee LN; Kuo SH; Luh KT
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2157-62. PubMed ID: 8520790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of microvascularization in cases of operated lung cancer.
    Szöke T; Kayser K; Baumhäkel JD; Trojan I; Furak J; Tiszlavicz L; Eller J; Boda K
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1106-11. PubMed ID: 15896626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
    Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
    Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
    Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.